Table 1.
Temporal trends in demographic and clinical data
| 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | p-valuea | |
|---|---|---|---|---|---|---|---|---|---|---|
| No. of women | 6 | 38 | 16 | 20 | 44 | 13 | 11 | 57 | 13 | -- |
|
| ||||||||||
| Age, y, mean | 19.3 | 20.7 | 20.5 | 20.9 | 21.2 | 22.7 | 22 | 22.3 | 22.7 | 0.500 |
|
| ||||||||||
| HIV pos, % | 40 | 39.5 | 29.4 | 47.4 | 29.3 | NA | 50 | 33.3 | NA | 0.827 |
|
| ||||||||||
| Primigravid, % | 83.3 | 52.6 | 41.2 | 40 | 64.4 | 53.9 | 36.4 | 56.4 | 53.4 | 0.808 |
|
| ||||||||||
| SP doses, % | ||||||||||
| 0 | 0 | 31.3 | 25 | 16.7 | 0 | 0 | 0 | 0 | 0 | |
| 1 | 75 | 46.9 | 50 | 72.2 | 44.4 | 25 | 30 | 21.2 | 15.4 | <0.001 |
| ≥2 | 25 | 21.8 | 25 | 11.2 | 55.6 | 75 | 70 | 78.8 | 84.6 | |
|
| ||||||||||
| SP doses, mean (SD) | 1.25 (0.5) | 1 (0.92) | 1 (0.73) | 1 (0.69) | 1.58 (0.55) | 1.92 (0.67) | 2 (0.94) | 2.21 (0.94) | 2.23 (0.83) | <0.001 |
|
| ||||||||||
| % last SP dose < 60 days prior to delivery b | NA | NA | 55.6 | 21.4 | 48.7 | 75 | 80 | 76.6 | 81.8 | 0.002 |
NA: not available; SD: standard deviation; HIV: human immunodeficiency virus; SP: sulfadoxine-pyrimethamine.
a
Calculated with oneway ANOVA for continuous data or the chi-squared test for categorical variables.
b
Of women who received SP.